Marina receives NoA for Smarticles delivery technology patent
The Smarticles delivery technology has been licensed to ProNAi, for delivery of single-stranded oligonucleotide therapeutics and to Mirna for delivery of double-stranded microRNA mimics. Marina R&D executive vice
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.